SQZ Biotechnologies Price to Sales Ratio 2020-2022 | SQZ
Historical PS ratio values for SQZ Biotechnologies (SQZ) over the last 10 years. The current P/S ratio for SQZ Biotechnologies as of June 28, 2022 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| SQZ Biotechnologies P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2022-06-28 |
3.25 |
|
3.69 |
| 2022-03-31 |
4.81 |
$0.88 |
5.45 |
| 2021-12-31 |
8.93 |
$0.99 |
9.04 |
| 2021-09-30 |
14.42 |
$1.00 |
14.42 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.095B |
$0.027B |
|
SQZ Biotechnologies Company is a clinical-stage biotechnology company. It develops transformative cell therapies for patients with cancer, infectious diseases and other serious conditions. The company's prime product candidate consist SQZ-PBMC-HPV which is in clinical stage. SQZ Biotechnologies Company is based In Watertown, Massachusetts.
|
